Verdict No. 3016 · Search date 2026-09-07 · Methodology v0.9
Medical-grade 16% manuka-honey drops or 98% gel added to existing lid care,
does it really help with Improved symptoms and selected signs of evaporative dry eye from meibomian gland dysfunction?
30-Second Summary
C
Evidence Grade C · 46 · Safety caution
Limited signals from medical-grade manuka formulations do not support food-honey self-instillation or established symptom benefit
Food honey, nonsterile products, and homemade dilutions can cause infection or corneal injury and must not be put in the eye. Even the studied ophthalmic formulation can cause initial stinging and redness and should be used with eye-care supervision. Stop and seek prompt ophthalmic care for pain, reduced vision, photophobia, discharge, or persistent redness.
What the
research showsGrade C with 46 points. An open three-arm trial of 114 added 16% drops or 98% gel to common warm compresses, lid massage, and preservative-free lubricant and found differences in selected staining and meibomian outcomes. In a 59-person assessor-masked trial, SPEED improvement was mainly presented as separate within-group P values, leaving the direct symptom effect uncertain.
research showsGrade C with 46 points. An open three-arm trial of 114 added 16% drops or 98% gel to common warm compresses, lid massage, and preservative-free lubricant and found differences in selected staining and meibomian outcomes. In a 59-person assessor-masked trial, SPEED improvement was mainly presented as separate within-group P values, leaving the direct symptom effect uncertain.
What the
ads claimThe claim that putting honey in the eye cures dry eye converts a sterile medical formulation into food honey and within-group improvement into direct product efficacy.
ads claimThe claim that putting honey in the eye cures dry eye converts a sterile medical formulation into food honey and within-group improvement into direct product efficacy.
Useful facts when choosing a product
- This is not evidence for food-grade manuka honey or homemade dilution.
- The 16% drop and 98% gel are different formulations.
- Temporary stinging and redness were reported.
Gap Measurement · Verdict 3016 · C 46
What the research actually shows
Ophthalmic medical-grade 16% drops or 98% gel were added to warm compresses, lid massage, and preservative-free lubricant, or compared with ordinary lubricant. The two formulations were kept separate.
Why this is classified as C (46)
Selected objective signs and assessor masking are useful, but missing direct symptom effects and precision, product involvement, open treatment, and multiple outcomes give C with 46 points.
Counterpoint. P=.006 in the honey group and P=.183 in control do not test whether the two changes differ and therefore do not establish superiority.
Rejudgment record. Cross-check applied — Separated 16% drops, 98% gel, and common lid care; did not convert within-group P values to between-group effects; distinguished symptoms, signs, and product involvement
Scoring profile behind this grade
| Endpoint | P | Patient-reported treatment goal - the symptom is the goal |
| Replication | R1 | Single confirmatory trial |
| Independence | I1 | Mixed funding sources |
| Effect size | EX | The clinical size of the effect could not be judged |
| Precision | CX | No pooled confidence interval could be confirmed |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Improved dry-eye symptoms over existing care | C | Different within-group P values do not establish direct superiority. |
| Improved selected staining or meibomian signs | C | These are formulation-specific signals from a small open multiple-outcome trial. |
| Self-instillation of food-grade manuka honey | F | There is no clinical evidence, and nonsterile ocular use can cause harm. |
Cross-check — AI research and Codex final gate
AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Albietz JM·Lenton LM. 2017 | Open three-arm randomized trial | 114 | Optimel product provision or related involvement reported | Symptoms, staining, tear film, meibum, colonization, and lubricant use | All groups improved; selected signals included staining with drops P=.035 and gel meibum quality P=.005 and expressibility P=.042 | Key adjunctive composite-treatment trial |
| Study 2 | Randomized assessor-masked trial | 55 | Specific Optimel product study and provision; author conflicts disclosed | Three-week SPEED, tear film, inflammation, and staining | Within-group SPEED changes 2.53 (P=.006) versus 1.087 (P=.183); direct symptom contrast not presented in abstract | Supporting symptom trial |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-09-07).
Albietz JM, Lenton LM. Randomised controlled trial of topical antibacterial Manuka honey for evaporative dry eye due to meibomian gland dysfunction. Clin Exp Optom. 2017. PMID: 28585260. DOI: 10.1111/cxo.12524.
checkedWong D, Albietz JM, Tran H, et al. Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in meibomian gland dysfunction. Br J Ophthalmol. 2021. PMID: 33419788. DOI: 10.1136/bjophthalmol-2020-317506. NCT04457648.
checkedResearch and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none
Cite this verdict
[Chamgap] Medical Manuka-Honey Drops and Gel for MGD Dry Eye—Within-Group Improvement Is Not the Product's Added Effect — Evidence Grade C·46. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/eye/medical-manuka-honey-drops-gel-meibomian-dry-eye/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.